Islet cell transplantation for the treatment of type 1 diabetes: recent advances and future challenges.
Ontology highlight
ABSTRACT: Islet transplantation is a well-established therapeutic treatment for a subset of patients with complicated type I diabetes mellitus. Prior to the Edmonton Protocol, only 9% of the 267 islet transplant recipients since 1999 were insulin independent for >1 year. In 2000, the Edmonton group reported the achievement of insulin independence in seven consecutive patients, which in a collaborative team effort propagated expansion of clinical islet transplantation centers worldwide in an effort to ameliorate the consequences of this disease. To date, clinical islet transplantation has established improved success with insulin independence rates up to 5 years post-transplant with minimal complications. In spite of marked clinical success, donor availability and selection, engraftment, and side eff
SUBMITTER: Bruni A
PROVIDER: S-EPMC4075233 | biostudies-literature | 2014
REPOSITORIES: biostudies-literature
ACCESS DATA